Biosynthesis and degradation of the endocannabinoid 2-arachidonoylglycerol

BioFactors

Volumn 37, Issue 1, 2011, Pages 1-7

  Ueda, Natsuo ^a   Tsuboi, Kazuhito ^a   Uyama, Toru ^a   Ohnishi, Taira ^a  

^a KAGAWA UNIVERSITY   (Japan)

Author keywords

Cannabinoid receptor; Diacylglycerol lipase; Monoacylglycerol lipase; Phospholipase C

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ACYLGLYCEROL LIPASE; ANANDAMIDE; DIACYLGLYCEROL; ENDOCANNABINOID; HYDROLASE; MONOACYLGLYCEROL;

ARTICLE; FATTY ACID SYNTHESIS; HUMAN; LIPID DEGRADATION; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ARACHIDONIC ACIDS; ENDOCANNABINOIDS; GLYCERIDES; HUMANS; LIPOPROTEIN LIPASE; MONOACYLGLYCEROL LIPASES; PROTEIN CONFORMATION;

MAMMALIA;

EID: 79951617104     PISSN: 09516433     EISSN: 18728081     Source Type: Journal    
DOI: 10.1002/biof.131     Document Type: Article

References (65)

1. Pacher, P., Bátkai, S., and Kunos, G. ( 2006) The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol. Rev. 58, 389-462.
2. Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., and Bonner, T. I. ( 1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346, 561-564.
3. Munro, S., Thomas, K. L., and Abu-Shaar, M. ( 1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature 365, 61-65.
4. De Petrocellis, L. and Di Marzo, V. ( 2010) Non-CB1, non-CB2 receptors for endocannabinoids, plant cannabinoids, and synthetic cannabimimetics: focus on G-protein-coupled receptors and transient receptor potential channels. J. Neuroimmune Pharmacol. 5, 103-121.
5. Ueda, N., Okamoto, Y., and Tsuboi, K. ( 2005) Endocannabinoid-related enzymes as drug targets with special reference to N-acylphosphatidyl-ethanolamine-hydrolyzing phospholipase D. Curr. Med. Chem. 12, 1413-1422.
6. Devane, W. A., Hanus, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., and Mechoulam, R. ( 1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258, 1946-1949.
7. Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., Pertwee, R. G., Griffin, G., Bayewitch, M., Barg, J., and Vogel, Z. ( 1995) Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem. Pharmacol. 50, 83-90.
8. Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., and Waku, K. ( 1995) 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem. Biophys. Res. Commun. 215, 89-97.
9. Sugiura, T., Kishimoto, S., Oka, S., and Gokoh, M. ( 2006) Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand. Prog. Lipid Res. 45, 405-446.
10. Prescott, S. M. and Majerus, P. W. ( 1983) Characterization of 1, 2-diacylglycerol hydrolysis in human platelets. Demonstration of an arachidonoyl-monoacylglycerol intermediate. J. Biol. Chem. 258, 764-769.
11. Kano, M., Ohno-Shosaku, T., Hashimotodani, Y., Uchigashima, M., and Watanabe, M. ( 2009) Endocannabinoid-mediated control of synaptic transmission. Physiol. Rev. 89, 309-380.
12. Di Marzo, V. ( 2008) Targeting the endocannabinoid system: to enhance or reduce? Nat. Rev. Drug Discov. 7, 438-455.
13. Ahn, K., McKinney, M. K., and Cravatt, B. F. ( 2008) Enzymatic pathways that regulate endocannabinoid signaling in the nervous system. Chem. Rev. 108, 1687-1707.
14. Ueda, N., Tsuboi, K., and Uyama, T. ( 2010) N-acylethanolamine metabolism with special reference to N-acylethanolamine-hydrolyzing acid amidase (NAAA). Prog. Lipid Res. 49, 299-315.
15. Ueda, N., Tsuboi, K., and Uyama, T. ( 2010) Enzymological studies on the biosynthesis of N-acylethanolamines. Biochim. Biophys. Acta. 1801, 1274-1285.
16. Fukami, K., Inanobe, S., Kanemaru, K., and Nakamura, Y. ( 2010) Phospholipase C is a key enzyme regulating intracellular calcium and modulating the phosphoinositide balance. Prog. Lipid Res. 49, 429-437.
17. 2+ dependency for triggering retrograde endocannabinoid signal. Neuron 45, 257-268.
18. 2+-assisted metabotropic glutamate receptor subtype 1 to phospholipase Cβ4 signaling cascade in the cerebellum. J. Neurosci. 25, 6826-6835.
19. Bisogno, T., Melck, D., De Petrocellis, L., and Di Marzo, V. ( 1999) Phosphatidic acid as the biosynthetic precursor of the endocannabinoid 2-arachidonoylglycerol in intact mouse neuroblastoma cells stimulated with ionomycin. J. Neurochem. 72, 2113-2119.
20. Oka, S., Yanagimoto, S., Ikeda, S., Gokoh, M., Kishimoto, S., Waku, K., Ishima, Y., and Sugiura, T. ( 2005) Evidence for the involvement of the cannabinoid CB2 receptor and its endogenous ligand 2-arachidonoylglycerol in 12-O-tetradecanoylphorbol-13-acetate-induced acute inflammation in mouse ear. J. Biol. Chem. 280, 18488-18497.
21. 1 followed by lysophosphoinositide-specific phospholipase C in rat brain. J. Neurochem. 61, 1874-1881.
22. Tsutsumi, T., Kobayashi, T., Ueda, H., Yamauchi, E., Watanabe, S., and Okuyama, H. ( 1994) Lysophosphoinositide-specific phospholipase C in rat brain synaptic plasma membranes. Neurochem. Res. 19, 399-406.
23. Nakane, S., Oka, S., Arai, S., Waku, K., Ishima, Y., Tokumura, A., and Sugiura, T. ( 2002) 2-Arachidonoyl-sn-glycero-3-phosphate, an arachidonic acid-containing lysophosphatidic acid: occurrence and rapid enzymatic conversion to 2-arachidonoyl-sn-glycerol, a cannabinoid receptor ligand, in rat brain. Arch. Biochem. Biophys. 402, 51-58.
24. Okazaki, T., Sagawa, N., Okita, J. R., Bleasdale, J. E., MacDonald, P. C., and Johnston, J. M. ( 1981) Diacylglycerol metabolism and arachidonic acid release in human fetal membranes and decidua vera. J. Biol. Chem. 256, 7316-7321.
25. Chau, L. Y. and Tai, H. H. ( 1981) Release of arachidonate from diglyceride in human platelets requires the sequential action of a diglyceride lipase and a monoglyceride lipase. Biochem. Biophys. Res. Commun. 100, 1688-1695.
26. Moriyama, T., Urade, R., and Kito, M. ( 1999) Purification and characterization of diacylglycerol lipase from human platelets. J. Biochem. 125, 1077-1085.
27. Bisogno, T., Howell, F., Williams, G., Minassi, A., Cascio, M. G., Ligresti, A., Matias, I., Schiano-Moriello, A., Paul, P., Williams, E. J., Gangadharan, U., Hobbs, C., Di Marzo, V., and Doherty, P. ( 2003) Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain. J. Cell Biol. 163, 463-468.
28. Jung, K. M., Astarita, G., Zhu, C., Wallace, M., Mackie, K., and Piomelli, D. ( 2007) A key role for diacylglycerol lipase-alpha in metabotropic glutamate receptor-dependent endocannabinoid mobilization. Mol. Pharmacol. 72, 612-621.
29. Tanimura, A., Yamazaki, M., Hashimotodani, Y., Uchigashima, M., Kawata, S., Abe, M., Kita, Y., Hashimoto, K., Shimizu, T., Watanabe, M., Sakimura, K., and Kano, M. ( 2010) The endocannabinoid 2-arachidonoylglycerol produced by diacylglycerol lipase alpha mediates retrograde suppression of synaptic transmission. Neuron 65, 320-327.
30. Gao, Y., Vasilyev, D. V., Goncalves, M. B., Howell, F. V., Hobbs, C., Reisenberg, M., Shen, R., Zhang, M. Y., Strassle, B. W., Lu, P., Mark, L., Piesla, M. J., Deng, K., Kouranova, E. V., Ring, R. H., Whiteside, G. T., Bates, B., Walsh, F. S., Williams, G., Pangalos, M. N., Samad, T. A., and Doherty, P. ( 2010) Loss of retrograde endocannabinoid signaling and reduced adult neurogenesis in diacylglycerol lipase knock-out mice. J. Neurosci. 30, 2017-2024.
31. Hoover, H. S., Blankman, J. L., Niessen, S., and Cravatt, B. F. ( 2008) Selectivity of inhibitors of endocannabinoid biosynthesis evaluated by activity-based protein profiling. Bioorg. Med. Chem. Lett. 18, 5838-5841.
32. Bisogno, T., Cascio, M. G., Saha, B., Mahadevan, A., Urbani, P., Minassi, A., Appendino, G., Saturnino, C., Martin, B., Razdan, R., and Di Marzo, V. ( 2006) Development of the first potent and specific inhibitors of endocannabinoid biosynthesis. Biochim. Biophys. Acta 1761, 205-212.
33. Bisogno, T., Burston, J. J., Rai, R., Allarà, M., Saha, B., Mahadevan, A., Razdan, R. K., Wiley, J. L., and Di Marzo, V. ( 2009) Synthesis and pharmacological activity of a potent inhibitor of the biosynthesis of the endocannabinoid 2-arachidonoylglycerol. ChemMedChem. 4, 946- 950.
34. Blankman, J. L., Simon, G. M., and Cravatt, B. F. ( 2007) A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol. Chem. Biol. 14, 1347-1356.
35. Kanoh, H., Iwata, T., Ono, T., and Suzuki, T. ( 1986) Immunological characterization of sn-1, 2-diacylglycerol and sn-2-monoacylglycerol kinase from pig brain. J. Biol. Chem. 261, 5597-5602.
36. Shim, Y. H., Lin, C. H., and Strickland, K. P. ( 1989) The purification and properties of monoacylglycerol kinase from bovine brain. Biochem. Cell Biol. 67, 233-241.
37. Coleman, R. A. and Haynes, E. B. ( 1986) Monoacylglycerol acyltransferase. Evidence that the activities from rat intestine and suckling liver are tissue-specific isoenzymes. J. Biol. Chem. 261, 224-228.
38. Kozak, K. R. and Marnett, L. J. ( 2002) Oxidative metabolism of endocannabinoids. Prostaglandins Leukot. Essent. Fatty Acids. 66, 211-220.
39. Rouzer, C. A. and Marnett, L. J. ( 2008) Non-redundant functions of cyclooxygenases: oxygenation of endocannabinoids. J. Biol. Chem. 283, 8065-8069.
40. Labar, G., Wouters, J., and Lambert, D. M. ( 2010) A review on the monoacylglycerol lipase: at the interface between fat and endocannabinoid signalling. Curr. Med. Chem. 17, 2588-2607.
41. Tornqvist, H. and Belfrage, P. ( 1976) Purification and some properties of a monoacylglycerol-hydrolyzing enzyme of rat adipose tissue. J. Biol. Chem. 251, 813-819.
42. Karlsson, M., Contreras, J. A., Hellman, U., Tornqvist, H., and Holm, C. ( 1997) cDNA cloning, tissue distribution, and identification of the catalytic triad of monoglyceride lipase. Evolutionary relationship to esterases, lysophospholipases, and haloperoxidases. J. Biol. Chem. 272, 27218-27223.
43. Karlsson, M., Reue, K., Xia, Y. R., Lusis, A. J., Langin, D., Tornqvist, H., and Holm, C. ( 2001) Exon-intron organization and chromosomal localization of the mouse monoglyceride lipase gene. Gene 272, 11-18.
44. Dinh, T. P., Carpenter, D., Leslie, F. M., Freund, T. F., Katona, I., Sensi, S. L., Kathuria, S., and Piomelli, D. ( 2002) Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc. Natl. Acad. Sci. USA 99, 10819-10824; Erratum ( 2002) 99, 13961.
45. Labar, G., Bauvois, C., Borel, F., Ferrer, J. L., Wouters, J., and Lambert, D. M. ( 2010) Crystal structure of the human monoacylglycerol lipase, a key actor in endocannabinoid signaling. ChemBioChem. 11, 218-227.
46. Dinh, T. P., Kathuria, S., and Piomelli, D. ( 2004) RNA interference suggests a primary role for monoacylglycerol lipase in the degradation of the endocannabinoid 2-arachidonoylglycerol. Mol. Pharmacol. 66, 1260-1264.
47. Goparaju, S. K., Ueda, N., Yamaguchi, H., and Yamamoto, S. ( 1998) Anandamide amidohydrolase reacting with 2-arachidonoylglycerol, another cannabinoid receptor ligand. FEBS Lett. 422, 69-73.
48. Goparaju, S. K., Ueda, N., Taniguchi, K., and Yamamoto, S. ( 1999) Enzymes of porcine brain hydrolyzing 2-arachidonoylglycerol, an endogenous ligand of cannabinoid receptors. Biochem. Pharmacol. 57, 417-423.
49. Muccioli, G. G., Xu, C., Odah, E., Cudaback, E., Cisneros, J. A., Lambert, D. M., López Rodríguez, M. L., Bajjalieh, S., and Stella, N. ( 2007) Identification of a novel endocannabinoid-hydrolyzing enzyme expressed by microglial cells. J. Neurosci. 27, 2883-2889.
50. Marrs, W. R., Blankman, J. L., Horne, E. A., Thomazeau, A., Lin, Y. H., Coy, J., Bodor, A. L., Muccioli, G. G., Hu, S. S., Woodruff, G., Fung, S., Lafourcade, M., Alexander, J. P., Long, J. Z., Li, W., Xu, C., Möller, T., Mackie, K., Manzoni, O. J., Cravatt, B. F., and Stella, N. ( 2010) The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors. Nat. Neurosci. 13, 951-957.
51. Minkkilä, A., Saario, S., and Nevalainen, T. ( 2010) Discovery and development of endocannabinoid-hydrolyzing enzyme inhibitors. Curr. Top. Med. Chem. 10, 828-858.
52. Petrosino, S. and Di Marzo, V. ( 2010) FAAH and MAGL inhibitors: therapeutic opportunities from regulating endocannabinoid levels. Curr. Opin. Investig. Drugs 11, 51-62.
53. Saario, S. M., Salo, O. M., Nevalainen, T., Poso, A., Laitinen, J. T., Järvinen, T., and Niemi, R. ( 2005) Characterization of the sulfhydryl-sensitive site in the enzyme responsible for hydrolysis of 2-arachidonoyl-glycerol in rat cerebellar membranes. Chem. Biol. 12, 649-656.
54. Labar, G., Bauvois, C., Muccioli, G. G., Wouters, J., and Lambert, D. M. ( 2007) Disulfiram is an inhibitor of human purified monoacylglycerol lipase, the enzyme regulating 2-arachidonoylglycerol signaling. ChemBioChem. 8, 1293-1297.
55. King, A. R., Dotsey, E. Y., Lodola, A., Jung, K. M., Ghomian, A., Qiu, Y., Fu, J., Mor, M., and Piomelli, D. ( 2009) Discovery of potent and reversible monoacylglycerol lipase inhibitors. Chem. Biol. 16, 1045-1052.
56. Hohmann, A. G., Suplita, R. L., Bolton, N. M., Neely, M. H., Fegley, D., Mangieri, R., Krey, J. F., Walker, J. M., Holmes, P. V., Crystal, J. D., Duranti, A., Tontini, A., Mor, M., Tarzia, G., and Piomelli, D. ( 2005) An endocannabinoid mechanism for stress-induced analgesia. Nature 435, 1108-1112.
57. Vandevoorde, S., Jonsson, K.-O., Labar, G., Persson, E., Lambert, D. M., and Fowler, C. J. ( 2007) Lack of selectivity of URB602 for 2-oleoylglycerol compared to anandamide hydrolysis in vitro. Br. J. Pharmacol. 150, 186-191.
58. Alexander, J. P. and Cravatt, B. F. ( 2006) The putative endocannabinoid transport blocker LY2183240 is a potent inhibitor of FAAH and several other brain serine hydrolases. J. Am. Chem. Soc. 128, 9699-9704.
59. Muccioli, G. G., Labar, G., and Lambert, D. M. ( 2008) CAY10499, a novel monoglyceride lipase inhibitor evidenced by an expeditious MGL assay. ChemBioChem. 9, 2704-2710.
60. Bisogno, T., Ortar, G., Petrosino, S., Morera, E., Palazzo, E., Nalli, M., Maione, S., Di Marzo, V., and Endocannabinoid Research Group ( 2009) Development of a potent inhibitor of 2-arachidonoylglycerol hydrolysis with antinociceptive activity in vivo. Biochim. Biophys. Acta 1791, 53-60.
61. Long, J. Z., Li, W., Booker, L., Burston, J. J., Kinsey, S. G., Schlosburg, J. E., Pavon, F. J., Serrano, A. M., Selley, D. E., Parsons, L. H., Lichtman, A. H., and Cravatt, B. F. ( 2009) Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects. Nat. Chem. Biol. 5, 37-44.
62. Long, J. Z., Nomura, D. K., and Cravatt, B. F. ( 2009) Characterization of monoacylglycerol lipase inhibition reveals differences in central and peripheral endocannabinoid metabolism. Chem. Biol. 16, 744-753.
63. Nomura, D. K., Blankman, J. L., Simon, G. M., Fujioka, K., Issa, R. S., Ward, A. M., Cravatt, B. F., and Casida, J. E. ( 2008) Activation of the endocannabinoid system by organophosphorus nerve agents. Nat. Chem. Biol. 4, 373-378.
64. Long, J. Z., Nomura, D. K., Vann, R. E., Walentiny, D. M., Booker, L., Jin, X., Burston, J. J., Sim-Selley, L. J., Lichtman, A. H., Wiley, J. L., and Cravatt, B. F. ( 2009) Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo. Proc. Natl. Acad. Sci. USA 106, 20270-20275.
65. Schlosburg, J. E., Blankman, J. L., Long, J. Z., Nomura, D. K., Pan, B., Kinsey, S. G., Nguyen, P. T., Ramesh, D., Booker, L., Burston, J. J., Thomas, E. A., Selley, D. E., Sim-Selley, L. J., Liu, Q. S., Lichtman, A. H., and Cravatt, B. F. ( 2010) Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system. Nat. Neurosci. 13, 1113-1119.